Article
Cantor Fitzgerald Reiterates Neutral on Pfizer, Maintains $27 Price Target
Cantor Fitzgerald analyst Carter Gould reiterates Pfizer (NYSE:PFE) with a Neutral and maintains $27 price target.
Comments
- No comments yet. Be the first to comment!